• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysis

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2024 Mar 21;24(1):339.
doi: 10.1186/s12879-024-09225-z. How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysis

Ying Chen[SUP] #[/SUP][SUP] 1 [/SUP], Wenhui Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Xinyue Han[SUP] 1 [/SUP], Miaoshuang Chen[SUP] 1 [/SUP], Xin Li[SUP] 1 [/SUP], Haiping Huang[SUP] 1 [/SUP], Mengyuan Zhang[SUP] 2 [/SUP], Rongjie Wei[SUP] 2 [/SUP], Huadong Zhang[SUP] 3 [/SUP], Changhong Yang[SUP] 4 [/SUP], Tao Zhang[SUP] 5 [/SUP]



Affiliations
Abstract

Background: There is a significant increase in the number of SARS-CoV-2 reinfection reports in various countries. However, the trend of reinfection rate over time is not clear.
Methods: We searched PubMed, Web of Science, Medline, Embase, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, and Wanfang for cohort studies, case-control studies, and cross-sectional studies up to March 16, 2023, to conduct a meta-analysis of global SARS-CoV-2 reinfection rate. Subgroup analyses were performed for age, country, study type, and study population, and time-varying reinfection rates of SARS-CoV-2 were estimated using meta-regression. The risk of bias was assessed using the Newcastle-Ottawa Scale and the Joanna Briggs Institute critical appraisal tool.
Result: A total of 55 studies involving 111,846 cases of SARS-CoV-2 reinfection were included. The pooled SARS-CoV-2 reinfection rate was 0.94% (95% CI: 0.65 -1.35%). In the subgroup analyses, there were statistically significant differences in the pooled reinfection rates by reinfection variant, and study type (P < 0.05). Based on meta-regression, the reinfection rate fluctuated with time.
Conclusion: Meta-regression analysis found that the overall reinfection rate increased and then decreased over time, followed by a period of plateauing and then a trend of increasing and then decreasing, but the peak of the second wave of reinfection rate was lower than the first wave. SARS-CoV-2 is at risk of reinfection and the Omicron variant has a higher reinfection rate than other currently known variants. The results of this study could help guide public health measures and vaccination strategies in response to the Coronavirus Disease 2019 (COVID-19) pandemic.

Keywords: COVID-19; Meta-analysis; Meta-regression; SARS-CoV-2; Time-varying reinfection rate.

 
Back
Top Bottom